The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era
about
The treatment of HIV-associated nephropathyIncomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureProteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsA survey of the management, control, and complications of diabetes mellitus in patients attending a diabetes clinic in Blantyre, Malawi, an area of high HIV prevalenceClinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patientsRelationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infectionNeither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension.Markers of renal disease and function are associated with systemic inflammation in HIV infection.Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) studyPlasma apolipoprotein L1 levels do not correlate with CKD.Impaired Urine Dilution Capability in HIV Stable Patients.
P2860
Q33610870-9141A72D-0D28-436D-B708-9CA4F92DA847Q33880241-4882BE67-16FA-4288-8EC8-71A467EB3812Q34048920-BA0E5912-F659-4732-A8E0-C65B8BB6E7CDQ34087385-BFF36CC2-367B-462B-A2A7-5F570BF6F586Q34736194-A1E5CB3D-C55A-4EC7-B45E-BD6925A32D70Q35126728-4B1963BB-2BEB-47AA-9EF0-05A11BF12B96Q35230397-4E130989-E7B2-4A10-B353-27CAE5372AF6Q35532872-23D065DB-DA4F-42D5-B782-D07FFC72414EQ36206108-85472E7A-03E4-41E7-8432-DC8374D20221Q36388998-F65A32C3-F6C3-4494-823C-CED219D6E73CQ37604753-589E868B-FFF3-4F53-A5F3-74D8F3835F5AQ37706095-EB376756-3188-4250-A3D8-DD4C16767283
P2860
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effects of HIV type-1 vira ...... ive antiretroviral therapy era
@en
The effects of HIV type-1 vira ...... ve antiretroviral therapy era.
@nl
type
label
The effects of HIV type-1 vira ...... ive antiretroviral therapy era
@en
The effects of HIV type-1 vira ...... ve antiretroviral therapy era.
@nl
prefLabel
The effects of HIV type-1 vira ...... ive antiretroviral therapy era
@en
The effects of HIV type-1 vira ...... ve antiretroviral therapy era.
@nl
P2093
P2860
P1433
P1476
The effects of HIV type-1 vira ...... ive antiretroviral therapy era
@en
P2093
AIDS Clinical Trials Group Longitudinal Linked Randomized Trials Study Team
Lynda A Szczech
Marlene Smurzynski
Nora Franceschini
Robert C Kalayjian
Ronald J Bosch
Samir K Gupta
P2860
P304
P577
2009-01-01T00:00:00Z